Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $24.74 USD
Change Today +0.74 / 3.08%
Volume 1.7M
CLDX On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 05/1/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Avery W. Catlin

Chief Financial Officer, Principal Accounting Officer, Senior Vice President, Treasurer and Secretary, Celldex Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 6 board members in 1 different organizations across 3 different industries.

See Board Relationships
66$1,223,869
As of Fiscal Year 2014

Background*

Mr. Avery W. Catlin, also known as Chip, has been the Chief Financial Officer and Senior Vice President at Celldex Therapeutics, Inc. since March 2008 and also serves as its Secretary and Treasurer. Mr. Catlin has been the Chief Financial Officer of CuraGen Corp., since October 2009. He served as the Chief Financial Officer, Senior Vice President and Secretary of AVANT Immunotherapeutics, Inc. since January 2000. He served as the Principal Accounting Officer and Treasurer ...

Read Full Background

Corporate Headquarters*

Perryville III Building
Hampton, New Jersey 08827

United States

Phone: 908-200-7500
Fax: 908-454-1911

Board Members Memberships*

2014-Present
Director

Education*

BA
University of Virginia
MBA
Babson College

Other Affiliations*

Annual Compensation*

Salary$317,017
Bonus$102,097
Total Annual Compensation$419,114

Stock Options*

All Other Compensation$5,717
Exercised Options10,000
Exercised Options Value$110,000
Exercisable Options284,750
Exercisable Options Value$3,386,786
Unexercisable Options208,250
Unexercisable Options Value$1,284,844
Total Value of Options$4,781,630
Total Number of Options503,000

Total Compensation*

Total Annual Cash Compensation$424,831
Total Short Term Compensation$419,114
Other Long Term Compensation$5,717
Total Calculated Compensation$1,223,869
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CLDX:US $24.74 USD +0.74

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Kevin T. Conroy Chairman of The Board, Chief Executive Officer and President
Exact Sciences Corporation
$861.1K
Stanley C. Erck Chief Executive Officer, President, Director and Member of Finance Committee
Novavax, Inc.
$448.3K
Stephen T. Isaacs Chairman, Chief Executive Officer and President
Aduro BioTech, Inc.
$886.6K
M. Michelle Berrey M.D., MPH.Chief Executive Officer, President, Chief Medical Officer and Director
Chimerix, Inc.
$419.3K
Paul Chaplin MSc, Ph.D.Chief Executive Officer and President
Bavarian Nordic A/S
--
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CELLDEX THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.